As per this study, the Global Spinal Muscular Atrophy (SMA) Treatment Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.
Spinal Muscular Atrophy (SMA) is a hereditary disease affecting the part of the nervous system that controls voluntary muscle movement. SMA disables people of physical strength by affecting the motor nerve cells of the spinal cord, taking away ability to eat, walk or breathe. It is the genetic cause of infant death globally. SMA affects 1 in 11,000 babies approximately. The only drug approved for the treatment of SMA is Spinraza. An alternative to this, gene therapy is another treatment used to treat SMA.
Market Dynamics
The increasing awareness by various NGO’s and the public regarding Spinal Muscular Atrophy (SMA) and a growing number of initiatives to improve treatment for rare diseases are fueling the market growth of SMA treatment. Moreover, improving the healthcare sector is again boosting the market growth. However, the high cost of treatment and lack of experienced professionals are some of the factors that restrain market growth. Whereas, innovation of more efficient drugs and therapies is expected to offer opportunities to SMA treatment market in the forecast period.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of spinal muscular atrophy (SMA) treatment.
Market Segmentation
The broad spinal muscular atrophy (SMA) treatment market has been sub-grouped into type, treatment and route of administration. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Type
1 PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 EXECUTIVE SUMMARY
2.1. Highlights of Spinal Muscular Atrophy (Sma) Treatment Market
2.2. Global Spinal Muscular Atrophy (Sma) Treatment Market Snapshot
3 SPINAL MUSCULAR ATROPHY (SMA) TREATMENT – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers of Spinal Muscular Atrophy (Sma) Treatment Market
3.3. Market Restraints of Spinal Muscular Atrophy (Sma) Treatment Market
3.4. Opportunities of Spinal Muscular Atrophy (Sma) Treatment Market
3.5. Trends of Spinal Muscular Atrophy (Sma) Treatment Market
3.6. Porter’s Five Force Analysis of Spinal Muscular Atrophy (Sma) Treatment Market
3.7. Spinal Muscular Atrophy (Sma) Treatment Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Type
3.7.2 Market Attractive Analysis by Treatment
3.7.3 Market Attractive Analysis by Route Of Administration
3.7.4 Market Attractive Analysis by Region
4 VALUE CHAIN ANALYSIS
4.1. Spinal Muscular Atrophy (Sma) Treatment Value Chain Analysis
4.2. Spinal Muscular Atrophy (Sma) Treatment Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Spinal Muscular Atrophy (Sma) Treatment Raw Material Manufactures List
4.2.3. Price Trend of Spinal Muscular Atrophy (Sma) Treatment Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 GLOBAL SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY TYPE
5.1 Overview by Type
5.2 Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis by Type
5.3 Market Analysis of Type 1 by Regions
5.4 Market Analysis of Type 2 by Regions
5.5 Market Analysis of Type 3 by Regions
5.6 Market Analysis of Type 4 by Regions
6 GLOBAL SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY TREATMENT
6.1 Overview by Treatment
6.2 Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis by Treatment
6.3 Market Analysis of Gene Therapy by Regions
6.4 Market Analysis of Drug by Regions
7 GLOBAL SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
7.1 Overview by Route Of Administration
7.2 Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis by Route Of Administration
7.3 Market Analysis of Oral by Regions
7.4 Market Analysis of Intrathecal by Regions
7.5 Market Analysis of by Regions
7.6 Market Analysis of by Regions
7.7 Market Analysis of by Regions
8 GLOBAL SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America
8.3.1. Overview
8.3.2. North America Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Country
8.3.3. United State
8.3.4. Rest of North America
8.4. Europe
8.4.1. Overview
8.4.2. Europe Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Market Segment
8.4.3. Europe Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Country
8.4.4. United Kingdom
8.4.5. France
8.4.6. Germany
8.4.7 Rest of Europe
8.5. Asia Pacific
8.5.1. Overview
8.5.2. Asia Pacific Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Market Segment
8.5.3. Asia Pacific Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Country
8.5.4. China
8.5.5. Japan
8.5.6. India
8.5.7. Rest of Asia Pacific
8.6. Latin America
8.6.1. Overview
8.6.2. Latin America Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Market Segment
8.6.3. Latin America Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Country
8.6.4. Brazil
8.6.5. Rest of Latin America
8.7. Middle East & Africa
8.7.1. Overview
8.7.2. Middle East & Africa Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Market Segment
8.7.3. Middle East & Africa Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Country
8.7.4. Middle East
8.7.5. Africa
9 COMPETITIVE LANDSCAPE OF THE SPINAL MUSCULAR ATROPHY (SMA) TREATMENT COMPANIES
9.1. Spinal Muscular Atrophy (Sma) Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10 COMPANY PROFILES OF SPINAL MUSCULAR ATROPHY (SMA) TREATMENT INDUSTRY
10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Avexis, Inc.
10.3.1. CompanyOverview
10.3.2. Financials
10.3.3. Products
10.3.4. RecentDevelopments
10.4.Biogen
10.4.1. CompanyOverview
10.4.2. Financials
10.4.3. Products
10.4.4. RecentDevelopments
10.5.Cytokinetics,Inc.
10.5.1. CompanyOverview
10.5.2. Financials
10.5.3. Products
10.5.4. RecentDevelopments
10.6.F.Hoffmann-LaRocheLtd
10.6.1. CompanyOverview
10.6.2. Financials
10.6.3. Products
10.6.4. RecentDevelopments
10.7.IonisPharmaceuticals,Inc.
10.7.1. CompanyOverview
10.7.2. Financials
10.7.3. Products
10.7.4. RecentDevelopments
10.8.NovartisAG
10.8.1. CompanyOverview
10.8.2. Financials
10.8.3. Products
10.8.4. RecentDevelopments
10.9.PayoneerInc.
10.9.1. CompanyOverview
10.9.2. Financials
10.9.3. Products
10.9.4. RecentDevelopments
10.10.PayPalHoldings,Inc.
10.10.1. CompanyOverview
10.10.2. Financials
10.10.3. Products
10.10.4. RecentDevelopments
10.11.PaytmMobileSolutionsPvtLtd
10.11.1. CompanyOverview
10.11.2. Financials
10.11.3. Products
10.11.4. RecentDevelopments
10.12.PayUGroup
10.12.1. CompanyOverview
10.12.2. Financials
10.12.3. Products
10.12.4. RecentDevelopments
10.13.Payza
10.13.1. CompanyOverview
10.13.2. Financials
10.13.3. Products
10.13.4. RecentDevelopments
10.14.RazorpaySoftwarePrivateLimited
10.14.1. CompanyOverview
10.14.2. Financials
10.14.3. Products
10.14.4. RecentDevelopments
10.15.SkrillLimited
10.15.1. CompanyOverview
10.15.2. Financials
10.15.3. Products
10.15.4. RecentDevelopments
10.16.VeriFoneHoldings,Inc.
10.16.1. CompanyOverview
10.16.2. Financials
10.16.3. Products
10.16.4. RecentDevelopments
10.17.WePay,Inc.
10.17.1. CompanyOverview
10.17.2. Financials
10.17.3. Products
10.17.4. RecentDevelopments
*Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
Avail customized purchase options to meet your exact research needs: